Resources Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in Acquisition of NOMAD Transportable Power Systems June 12, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Ocean Capital Acquisition Corporation in $115 Million Initial Public Offering June 12, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $150 Million Initial Public Offering of JAB Acquisition Corp I June 10, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $5.4 Million Registered Direct Offering of Core AI Holdings, Inc. June 10, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in $16.6 Million Registered Direct Offering June 8, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $4.7 Million Best-Efforts Offering June 1, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents NextNRG, Inc. in $6.4 Million Private Placement Offering June 1, 2026 Read More › SRFC Client Alert: SEC Proposes Significant Overhaul of Public Company Filer Status Framework May 29, 2026 Read More › SRFC Client Alert: SEC Proposes Comprehensive Overhaul of Registered Offering Framework May 29, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Fincadia Advisors in $70.13 Million Series Investing in Shield AI May 27, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Fincadia Advisors in $10.85 Million Series Investing in Erebor May 27, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2.42 Million Series Investing in OpenAI May 22, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Ladenburg Thalmann & Co. Inc. in $10 Million Public Offering of QT Imaging Holdings May 22, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2 Million Registered Direct Offering of Jupiter Neurosciences May 22, 2026 Read More › SRFC Client Alert: SEC Approves Stringent New Nasdaq Listing Requirements for China-Based Companies May 21, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma Inc. in Up to $18 Million Public Offering May 20, 2026 Read More › Sichenzia Ross Ference Carmel LLP Sponsors “Secondary is Primary” Panel Discussion Event at New York Tech Week 2026 May 19, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents E.F. Hutton in $5 Million Public Offering of XORTX Therapeutics May 18, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2 Million Registered Direct Offering of NanoViricides May 18, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $7.2 Million Public Offering of CEL-SCI Corporation May 15, 2026 Read More › SRFC Client Alert: SEC Proposes Optional Semi-Annual Financial Reporting to Replace Quarterly Reports May 14, 2026 Read More › 1 2 3 … 86 Next »
